HK1116054A1 - A process for the preparation of a piroxicam: betacyclodextrin inclusion compound - Google Patents

A process for the preparation of a piroxicam: betacyclodextrin inclusion compound

Info

Publication number
HK1116054A1
HK1116054A1 HK08105435.4A HK08105435A HK1116054A1 HK 1116054 A1 HK1116054 A1 HK 1116054A1 HK 08105435 A HK08105435 A HK 08105435A HK 1116054 A1 HK1116054 A1 HK 1116054A1
Authority
HK
Hong Kong
Prior art keywords
piroxicam
preparation
inclusion compound
betacyclodextrin inclusion
betacyclodextrin
Prior art date
Application number
HK08105435.4A
Other languages
English (en)
Inventor
Roberto Pighi
Andersen Soeren Fjordgaard
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HK1116054A1 publication Critical patent/HK1116054A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK08105435.4A 2004-08-02 2008-05-16 A process for the preparation of a piroxicam: betacyclodextrin inclusion compound HK1116054A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04018261 2004-08-02
PCT/EP2005/008105 WO2006013039A2 (en) 2004-08-02 2005-07-26 A process for the preparation of a piroxicam: beta­cyclodextrin inclusion compound

Publications (1)

Publication Number Publication Date
HK1116054A1 true HK1116054A1 (en) 2008-12-19

Family

ID=35502714

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08105435.4A HK1116054A1 (en) 2004-08-02 2008-05-16 A process for the preparation of a piroxicam: betacyclodextrin inclusion compound

Country Status (18)

Country Link
US (1) US20090012284A1 (xx)
EP (1) EP1793862B1 (xx)
JP (1) JP2008508332A (xx)
KR (1) KR20070038109A (xx)
CN (1) CN101123989B (xx)
AT (1) ATE502653T1 (xx)
AU (1) AU2005268972A1 (xx)
DE (1) DE602005027092D1 (xx)
HK (1) HK1116054A1 (xx)
IL (1) IL181101A0 (xx)
MA (1) MA28849B1 (xx)
MX (1) MX2007001237A (xx)
NO (1) NO20070669L (xx)
PL (1) PL1793862T3 (xx)
PT (1) PT1793862E (xx)
TN (1) TNSN07012A1 (xx)
WO (1) WO2006013039A2 (xx)
ZA (1) ZA200700946B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101491529B (zh) * 2009-01-23 2011-04-06 上海微丸医药开发有限公司 一种吡罗昔康β-环糊精包合物微丸胶囊的制备方法
BR102012009317B1 (pt) * 2012-04-20 2022-05-31 Universidade Federal De Minas Gerais - Ufmg Processo de preparação de compostos de inclusão envolvendo ciclodextrinas e fármacos, usando um sistema de fluxo contínuo
WO2014161131A1 (en) * 2013-04-01 2014-10-09 Arissa Pharma PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
MX363389B (es) * 2013-12-12 2019-03-20 Synthon Bv Composicion farmaceutica que comprende ivabradina amorfa.
WO2016193096A1 (en) * 2015-05-29 2016-12-08 Givaudan Sa Spray drying
US20170056253A1 (en) * 2015-08-28 2017-03-02 Fitesa Nonwoven, Inc. Absorbent Article Having A High Content Of Bio-Based Materials
PL3565602T3 (pl) * 2017-01-09 2021-09-13 SciPharm S.à r.l. Nowy sposób wytwarzania rozpuszczalnej w wodzie forskoliny
CN116439916A (zh) * 2017-09-21 2023-07-18 宝洁公司 吸收制品
CN110575550A (zh) * 2019-08-13 2019-12-17 大梆(沈阳)动物保健有限公司 一种遮蔽兽用复方中药不良嗅味的方法
CN112471565A (zh) * 2020-12-18 2021-03-12 鲁南制药集团股份有限公司 一种挥发油喷雾研磨包合设备

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
RU2143896C1 (ru) * 1993-03-05 2000-01-10 Хексаль Аг Кристаллический комплекс циклодекстрина с гидрохлоридом ранитидина, способ его получения и содержащие его фармацевтические составы
KR20030041577A (ko) * 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions

Also Published As

Publication number Publication date
PT1793862E (pt) 2011-04-08
JP2008508332A (ja) 2008-03-21
KR20070038109A (ko) 2007-04-09
PL1793862T3 (pl) 2011-08-31
CN101123989A (zh) 2008-02-13
NO20070669L (no) 2007-05-02
IL181101A0 (en) 2007-07-04
MA28849B1 (fr) 2007-09-03
US20090012284A1 (en) 2009-01-08
MX2007001237A (es) 2007-04-18
DE602005027092D1 (de) 2011-05-05
WO2006013039A2 (en) 2006-02-09
WO2006013039A3 (en) 2007-08-23
EP1793862B1 (en) 2011-03-23
EP1793862A2 (en) 2007-06-13
CN101123989B (zh) 2010-12-15
ATE502653T1 (de) 2011-04-15
ZA200700946B (en) 2008-06-25
TNSN07012A1 (en) 2008-06-02
AU2005268972A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
HK1116054A1 (en) A process for the preparation of a piroxicam: betacyclodextrin inclusion compound
HK1080720A1 (en) A process for the preparation of piroxicam: b-cyclodextrin inclusion compounds
WO2008003766A3 (en) 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
WO2008012542A8 (en) Polysaccharide derivatives of erythropoietin
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
WO2007115210A3 (en) Non-starchy rice bran polysaccharides
WO2006077024A3 (en) 5-aminoindole derivatives
AU2007307111A1 (en) High-purity large-scale preparation of stannsoporfin
IL194613A (en) A crystalline isomaltulose composition with improved flow properties and a method for preparing it
MX2009011254A (es) Derivados de purinas sustituidas que contienen 2,6-dinitrogeno, preparacion y usos de los mismos.
TW200635586A (en) Composition comprising an epothilone and methods for producing a composition comprising an epothilone
HK1043117A1 (en) Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds
WO2009043577A3 (de) 19-nor-progesterone zur kontrazeption
WO2010018474A3 (fr) Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques
WO2007079715A3 (de) Neue lysolipin derivate
GEP20156227B (en) Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
WO2008102584A1 (ja) 新規フラバノール化合物及びその製造方法
TN2010000394A1 (en) Pharmaceutical composition
UA93197C2 (ru) Производные пиразолиламинопиридина, способ их получения, их применения и фармацевтическая композиция (варианты)
WO2007026372A3 (en) Novel crystalline polymorph of trandolapril and a process for preparation thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150726